Global Non-PVC IV Bags Market

Non-PVC IV Bags Market Size, Share, Growth Analysis, By Product (Single Chamber, Multi Chamber), By Material (Ethylene Vinyle Acetate, Polypropylene), By Content (Frozen Mixture, Liquid Mixture), By Region - Industry Forecast 2025-2032


Report ID: SQMIG35B2050 | Region: Global | Published Date: December, 2024
Pages: 157 | Tables: 64 | Figures: 75

Non-PVC IV Bags Market Insights

Non-PVC IV Bags Market size was valued at USD 1.73 Billion in 2023 and is poised to grow from USD 1.92 Billion in 2024 to USD 4.4 Billion by 2032, growing at a CAGR of 10.9% during the forecast period (2025-2032).

Non-PVC IV bags are considered to be naturally safe and practical to handle and transport. The use of these bags is crucial in operating rooms. These bags are in higher demand in the oncology division. Non-PVC IV bags are used to prevent contamination and assist in lowering the risk connected with using conventional IV bags. Traditional IV bags contain elements like PVC that could interact with the medications inside and cause undesirable compounds to develop. Drugs in IV bags do not react with non-PVC IV bags, and they are simple to discard.

Parenteral feeding and chemotherapy are the two main uses for non-PVC IV bags. PVC packaging is probably going to be replaced by non-PVC equivalents like polypropylene and EVA with the introduction of several sorts of alternatives like EVA and polypropylene. These materials can be used for a variety of tasks, including custom combinations and cold or frozen storage. Therefore, the non-PVC IV bags market is anticipated to develop over the forecast period because to the wide range of applications for these bags.

US Non-PVC IV Bags Market  is poised to grow at a sustainable CAGR for the next forecast year.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Non-PVC IV Bags Market size was valued at USD 1.73 Billion in 2023 and is poised to grow from USD 1.92 Billion in 2024 to USD 4.4 Billion by 2032, growing at a CAGR of 10.9% during the forecast period (2025-2032).

Global non-PVC IV bags market is relatively fragmented, with a high level of competition. Many businesses are putting an emphasis on organic growth initiatives, including new launches, product approvals, and others like patents and events. Acquisitions and partnerships & collaborations were two examples of inorganic growth tactics in the market. These actions have made it possible for market participants to grow their consumer bases and operations. With the increasing demand for non-PVC IV bags in the global industry, it is projected that market participants for non-PVC IV bags would have profitable growth prospects in the future.  'Baxter ', 'B. Braun Melsungen AG ', 'Pfizer, Inc. (Hospira) ', 'Fresenius Kabi AG ', 'JW Life Science ', 'RENOLIT ', 'PolyCine GmbH ', 'Sealed Air ', 'ANGIPLAST PVT. LTD ', 'Shanghai Solve Care Co Ltd. ', 'Kraton Corporation ', 'Jiangxi Sanxin Medtec Co., Ltd. ', 'Otsuka Pharmaceutical Co., Ltd ', 'Fresenius Kabi AG ', 'PolyCine GmbH'

Since chemotherapy involves administering drugs orally or intravenously (IV), factors such the rising cancer prevalence are anticipated to fuel market expansion throughout the forecast period. For instance, the World Health Organization (WHO) reports that cancer is the second biggest cause of death worldwide.

According to predictions, the use of ethylene vinyl acetate (EVA) in blood banks and the storage of frozen mixture will both expand in the next years. Additionally, as there are more blood banks globally, there is a growing need for storage of blood and blood components, which is growing both in awareness and demand. Due to a number of advantages such as chemical resistance, durability, clarity, and capacity to endure numerous sterilizing processes, the copolyester ether market is also expected to present a lucrative opportunity over the anticipated period.

North America held the largest share of the non-PVC IV bags market. The need for non-PVC IV containers, which can treat patients without endangering them, has surged in the United States as a result of stringent rules aimed at enhancing patient safety. Additionally, as the incidence of stomach cancer has grown over the past few years, so too has the demand for IV bags. For instance, according to the American Cancer Society, there will likely be 27,600 cases of stomach cancer diagnosed in the United States in 2020, which implies that 11,010 patients will pass away from the disease. Stomach cancer patients are unable to swallow food, thus they must fully rely on total parenteral nutrition to meet their nutritional needs and ensure their life.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Non-PVC IV Bags Market

Report ID: SQMIG35B2050

$5,300
BUY NOW GET FREE SAMPLE